CARVYKTI Continued Performance Reflects Growing Confidence In CAR-T Therapies For Multiple Myeloma Delveinsight
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promis ...
Le Lézard3d
Dry Age-Related Macular Degeneration Epidemiology Forecast 2020-2034 - ResearchAndMarkets.com
The "Dry Age-Related Macular Degeneration - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The "Dry AMD -Epidemiology - 2034" report delivers an in-depth ...
DARZALEX Continues to Redefine Multiple Myeloma Treatment with Robust Market Performance | DelveInsight
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
Parainfluenza Virus Infection Market to Expand Significantly by 2034, States DelveInsight Report | Ansun Biopharma, AlloVir, MedImmune
The Parainfluenza Virus Infection market is expected to surge due to the disease's increasing prevalence and awareness during ...
DelveInsight Business Research, LLP: CABLIVI Market Reports Positive Growth - Strong Momentum Expected to Continue | DelveInsight
Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...
VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight
DelveInsight's "VITRAKVI Market Size, Forecast, and Market Insight Report" highlights the details around VITRAKVI, a TRK, ...
Graft Versus Host Disease Market is Projected for Substantial Expansion from USD 1.3 Billion in 2023| DelveInsight
DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...
DelveInsight Business Research, LLP: BREYANZI Demonstrates Continued Growth in the Competitive CAR-T Market | DelveInsight
BREYANZI has significant market potential due to its innovative approach as a CD19-directed chimeric antigen receptor (CAR) T-cell therapy. The growing prevalence of hematologic malignancies ...
Euronews14d
Why is far-right AfD dominating in northeast Germany?
Germany's snap elections, which took place just two weeks ago, saw the far-right party, Alternative for Germany (AfD), win its best-ever result. In the north-eastern state of Mecklenburg ...